Cardiol Therapeutics Inc. - COM CL A (CRDL)

Q2 2023 13F Holders as of 6/30/2023

Type / Class
Equity / COM CL A
Number of holders
29
Total Shares
6.68M
Shares change
-563K
Total reported value, excl. options
$5.96M
Value change
-$451K
Put/Call ratio
0
Number of buys
10
Number of sells
-14
Price
$0.89
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.